Latest Proteasome Stories
NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Alzheimer's disease affects approximately 5.2 million people in the United States alone, and it is the nation's sixth leading cause of death.
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer.
Five Distinguished Researchers Receive First-Time Grant WHITE PLAINS, N.Y., Jan.
Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery, increased R&D spending in the development of epigenetic tools and assays for Histone Methyltransferases
Reportbuyer.com just published a new market research report:
According to a new technical market research report, the global ubiquitin proteasome research and development market was valued at nearly $2.9 billion in 2013.
Molecular biologists in the School of Medicine at The University of Texas Health Science Center San Antonio have found a novel way to fine-tune the activity of cells' protein-disposing machinery, with potentially cancer-fighting effects.
Cells have a sophisticated system to control and dispose of defective, superfluous proteins and thus to prevent damage to the body.
Scientists have devised a method for delivering tumor cell-killing enzymes in a way that protects the enzyme until it can do its work inside the cell.
Proteins, unlike diamonds, aren't forever.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.